XML 26 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities      
Net income $ 110,747 $ 64,853 $ 437,416
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 65,333 65,496 54,454
Impairment of intangible assets 13,364   285
Stock-based compensation 27,456 16,317 20,113
Amortization of premium on marketable securities and deferred financing costs 225 233 1,121
Earnings of equity method investments     (6,188)
Deferred income taxes (17,265) (5,407) (15,161)
Loss on extinguishment of debt     14,339
Other losses on disposals of assets 260 226 209
Adjustment to the gain on divestiture, net of tax / Gain on divestiture, net of tax 948 319 (408,575)
Contingent transaction fees paid stemming from divestiture     (13,388)
Taxes paid stemming from divestiture   (91,500)  
Changes in operating assets and liabilities, net of acquisitions and divestiture:      
Accounts receivable (69,643) (18,755) (11,445)
Inventories (50,443) (13,144) (2,933)
Prepaid expenses and other assets (15,968) 25,642 (16,009)
Accounts payable 30,967 792 4,695
Deferred revenue (3,939) (139) 4,213
Accrued warranty and retrofit costs 54 760 1,109
Accrued compensation and tax withholdings 7,298 11,097 (6,453)
Accrued restructuring costs 124 (865) 399
Proceeds from recovery on insurance claim     1,082
Accrued expenses and other liabilities 50,339 (18,059) 31,615
Net cash provided by (used in) operating activities 149,857 37,866 90,898
Cash flows from investing activities      
Purchases of property, plant and equipment (52,805) (39,924) (23,861)
Purchases of marketable securities (151) (10,894) (35,225)
Sales of marketable securities 25 2,492 48,903
Maturities of marketable securities 96 42,328 2,557
Proceeds from divestiture     661,642
Adjustment to proceeds from divestiture (1,802)    
Acquisitions, net of cash acquired (93,712) (15,744) (442,704)
Settlement (issuance) of note receivables 2,000 (1,000)  
Net cash (used in) provided by investing activities (146,349) (22,742) 211,312
Cash flows from financing activities      
Proceeds from term loans, net of discount     686,386
Proceeds from issuance of common stock 5,812 4,595 3,422
Payments of financing costs     (687)
Principal payments on debt (828) (828) (850,190)
Payments of finance leases (1,164) (1,277) (1,197)
Common stock dividends paid (29,726) (29,513) (28,895)
Net cash used in financing activities (25,906) (27,023) (191,161)
Effects of exchange rate changes on cash and cash equivalents 5,205 9,254 (3,586)
Net decrease in cash, cash equivalents and restricted cash (17,193) (2,645) 107,463
Cash, cash equivalents and restricted cash, beginning of period 302,526 305,171 197,708
Cash, cash equivalents and restricted cash, end of period 285,333 302,526 305,171
Supplemental disclosures:      
Cash paid for interest 1,435 2,159 20,799
Cash paid for income taxes, net $ 38,020 $ 102,010 $ 16,990